Home-based exercise programme
BehavioralA 12 week, online delivered, home-based exercise programme.
NCT Number: NCT05807386
The study aims to implement a 12-week home-based exercise programme utilising an online intervention delivery platform. The focus will be on increasing exercise behaviour within the participant's home setting using aerobic, resistance and flexibility exercises as well as behaviour change techniques. Following the programme, semi-structured interviews will be conducted, to explore participant experiences.
It is hypothesised that the exercise programme will be feasible, accessible and acceptable.
Trial opening soon.
Get Notified18 year–64 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 12 week, online delivered, home-based exercise programme.
Time frame: Calculated at trial end, i.e.12 weeks after inclusion.
Recruitment rate will be calculated by dividing the number of eligible candidates by the number who consent to participate.
Time frame: Calculated at trial end, i.e. 12 weeks after inclusion.
Attrition rate will be defined and calculated as discontinuation of the intervention without return.
Time frame: Calculated at trial end, i.e. 12 weeks after inclusion.
Adherence will calculated by monitoring the online platform engagement and outputs from post exercise session questionnaires.
Time frame: Calculated at trial end, i.e. 12 weeks after inclusion.
Engagement will be calculated by monitoring participant's activity on the online platform.
Time frame: Calculated at trial end, i.e. 12 weeks after inclusion.
Completion rate will be calculated by dividing the number of participants who successfully complete the programme, by the number of participants that attempt.
Time frame: Evaluated after intervention period, i.e. up to 12 weeks after inclusion offer.
Interviews will take place between the researcher and participant to explore their experience on the programme and identifying areas for improvement. This may be with participants who completed the intervention, withdrew or declined to participate.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Participant Body Mass will be measured using calibrated, digital scales.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Participant Body Fat Mass will be measured using the BiodyXpertZMII.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Participant Body Fat Percentage will be measured using the BiodyXpertZMII.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Participant Fat Free Mass will be measured using the BiodyXpertZMII.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
BMI will be calculated from combining body mass (kg) and participant height (cm).
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Waist to hip ratio will be calculated from combining measures of waist circumference (cm) and hip circumference (cm).
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
Resting diastolic and systolic blood pressure (mmHg) will be taken using a blood pressure monitor.
Time frame: Taken at baseline and 12 weeks/programme completion.
This will be measured using the Six Minute Walk test and change will be compared within and between participants.
Time frame: Taken at baseline and 12 weeks/programme completion.
This will be measured using the 30s Sit to Stand test and change will be compared within and between participants.
Time frame: Taken at baseline and 12 weeks/programme completion.
This will be measured using the hand grip dynamometer, and change will be compared within and between participants.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
This will be measured using the European Quality of Life Five Dimension Questionnaire (EQ-5D-5L), and change will be compared within and between participants. Scores range from 1-5 with lower scores associated with a better outcome.
Time frame: Taken at baseline, 6 weeks and 12 weeks/programme completion.
This will be measured using the International Physical Activity Questionnaire - Long Form (IPAQ-LF), and change will be compared within and between participants. Scores may be categorised and/or sub scores calculated for each domain where higher scores are associated with better physical activity behaviour.
Time frame: Three/four times weekly, throughout the 12 week programme, after each exercise session is complete.
Exercise intensity will be recorded using the Borg Category Ratio (CR-10) scale, and change will be compared to the prescribed programme intensity. Higher scores are associated with a higher exercise intensity.
Time frame: Three/four times weekly, throughout the 12 week programme, after each exercise session is complete.
Exercise feeling will be recorded using the Feeling Scale, that ranges from -5 to +5, where -5 indicates feeling 'Very Bad' and +5 indicates feeling 'Very Good'.
Contact information is provided by the study sponsor or research team.
Coventry University
Other
WE Are Active and In This toGetHer (WEIGH): a Randomised Controlled Trial to Ascertain the Feasibility of a Home-based Exercise Programme for People Living With Overweight and Obesity
Acronym: WEIGH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07724431
Body Weight, Body Weight Changes
Melbourne, Victoria, Australia
View Trial DetailsNCT07696403
Body Weight, Dyslipidemia
Athens, Georgia, United States
View Trial DetailsNCT07629544
Body Weight, Nutrition Disorders
Beijing, China
View Trial DetailsNCT07584330
Body Weight, Diabetes Mellitus
View Trial Details